Acrolein produced during acute kidney injury promotes tubular cell death

Seishi Aihara1, Kumiko Torisu2, Yutaro Hirashima1

  • 1Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Insights

Toxic acrolein, produced from polyamines during cell damage, worsens acute kidney injury (AKI) by causing tubular cell death. Controlling acrolein levels may offer a new therapeutic strategy for kidney ischemia-reperfusion injury.

Area of Science:

  • Nephrology
  • Cellular Biology
  • Toxicology

Background:

  • Acute kidney injury (AKI) presents a significant global health challenge with high morbidity and mortality rates.
  • Polyamines are crucial for cellular functions, but their breakdown product, acrolein, can be toxic.
  • Spermine oxidase (SMOX) is an enzyme responsible for producing acrolein from polyamines during cellular damage.

Purpose of the Study:

  • To investigate the role of acrolein in exacerbating AKI through renal tubular cell death.
  • To explore the therapeutic potential of targeting acrolein accumulation in ischemia-reperfusion injury.

Main Methods:

  • Utilized a mouse model of renal ischemia-reperfusion injury and human proximal tubule cells (HK-2).
  • Quantified acrolein levels using acroleinRED and assessed SMOX expression.
  • Investigated the effects of acrolein and its scavenger cysteamine on cell death and fibrosis markers (TGFB1).
  • Examined mitochondrial membrane potential and employed siRNA-mediated knockdown of SMOX.

Main Results:

  • Acrolein levels were elevated in ischemia-reperfusion injured kidneys and in HK-2 cells undergoing hypoxia-reoxygenation.
  • Acrolein exposure induced cell death and increased TGFB1 mRNA expression in HK-2 cells.
  • Cysteamine treatment reduced acrolein-induced TGFB1 upregulation, preserved mitochondrial membrane potential, and decreased cell death.
  • SMOX knockdown mitigated hypoxia-reoxygenation-induced acrolein accumulation and cell death.

Conclusions:

  • Acrolein significantly contributes to renal tubular cell death and exacerbates AKI during ischemia-reperfusion injury.
  • Targeting acrolein accumulation, potentially via scavengers like cysteamine, represents a promising therapeutic avenue for AKI.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
37
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
39
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
42
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
30
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
46
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
38